Influenza Other Respir Viruses. 2014 May;8(3):339-46. doi: 10.1111/irv.12241.
To review neurological complications after the influenza A (H1N1) pdm09, highlighting the clinical differences between patients with post-vaccine or viral infection.
A search on Medline, Ovid, EMBASE, and PubMed databases using the keywords “neurological complications of Influenza AH1N1” or “post-vaccine Influenza AH1N1.”
Only papers written in English, Spanish, German, French, Portuguese, and Italian published from March 2009 to December 2012 were included.
We included 104 articles presenting a total of 1636 patient cases. In addition, two cases of influenza vaccine-related neurological events from our neurological care center, arising during the period of study, were also included.
Demographic data and clinical diagnosis of neurological complications and outcomes: death, neurological sequelae or recovery after influenza A (H1N1) pdm09 vaccine or infection.
The retrieved cases were divided into two groups: the postvaccination group, with 287 patients, and the viral infection group, with 1349 patients. Most patients in the first group were adults. The main neurological complications were Guillain-Barre syndrome (GBS) or polyneuropathy (125), and seizures (23). All patients survived. Pediatric patients were predominant in the viral infection group. In this group, 60 patients (4.7%) died and 52 (30.1%) developed permanent sequelae. A wide spectrum of neurological complications was observed.
Fatal cases and severe, permanent, neurological sequelae were observed in the infection group only. Clinical outcome was more favorable in the post-vaccination group. In this context, the relevance of an accurate neurological evaluation is demonstrated for all suspicious cases, as well as the need of an appropriate long-term clinical and imaging follow-up of infection and post-vaccination events related to influenza A (H1N1) pdm09, to clearly estimate the magnitude of neurological complications leading to permanent disability.
综述甲型 H1N1(pdm09)流感后的神经并发症,重点分析疫苗接种后和病毒感染后患者的临床差异。
在 Medline、Ovid、EMBASE 和 PubMed 数据库中使用“流感 A H1N1 的神经并发症”或“疫苗接种后流感 A H1N1”等关键词进行检索。
仅纳入 2009 年 3 月至 2012 年 12 月发表的英语、西班牙语、德语、法语、葡萄牙语和意大利语的文献。
纳入 104 篇文章,共纳入 1636 例患者。此外,还纳入了研究期间我们神经科治疗中心的 2 例与流感疫苗相关的神经事件。
人口统计学数据和神经并发症及结局的临床诊断:死亡、流感 A(H1N1)pdm09 疫苗或感染后的神经后遗症或恢复。
检索到的病例分为两组:疫苗接种组 287 例,病毒感染组 1349 例。第一组患者多为成年人,主要神经并发症为格林-巴利综合征(GBS)或多神经病(125 例)和癫痫发作(23 例)。所有患者存活。病毒感染组患者以儿科患者为主,该组 60 例(4.7%)死亡,52 例(30.1%)遗留永久性后遗症。观察到广泛的神经并发症谱。
仅在感染组观察到致死病例和严重、永久性的神经后遗症。疫苗接种组的临床结局更好。在此背景下,所有疑似病例均需要进行准确的神经评估,且需要对流感 A(H1N1)pdm09 感染和疫苗接种相关事件进行适当的长期临床和影像学随访,以明确导致永久性残疾的神经并发症的严重程度。